dpp 4 glp 1 combination It's the first in a class of drugs called DPP-4 inhibitors DPP4 Inhibitors vs GLP-1 Agonists

Feb 2011;25(1):159-166

Retatrutide Retatrutide represents another approach to multi-pathway activation, functioning as a triple agonist (GIP/GLP-1/glucagon) in a single molecule: Cagrilintide + GLP-1 Approach: Two separate injections Amylin + GLP-1 pathways Established safety profile for each component Flexible dose adjustment of each component Retatrutide Approach: Single injection GIP + GLP-1 + Glucagon pathways Novel triple mechanism in one molecule Fixed ratio of pathway activation Both approaches show promise for significant metabolic benefits, though they achieve multi-pathway activation through different strategies

DM, diabetes mellitus

GLP-1s reduce overall body fat, but do not sculpt or contour specific areas

Our master nurse injectors understand this concern, so heres how we make your journey easier, more efficient, and patient-friendly at InjectCo: 1